Lack of mutations in EGFR in gastroenteropancreatic neuroendocrine tumors

N Engl J Med. 2005 Jul 14;353(2):209-10. doi: 10.1056/NEJM200507143530219.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • DNA Mutational Analysis
  • Drug Resistance, Neoplasm / genetics
  • ErbB Receptors / genetics*
  • Gastrointestinal Neoplasms / drug therapy
  • Gastrointestinal Neoplasms / genetics
  • Gefitinib
  • Humans
  • Molecular Sequence Data
  • Mutation*
  • Neuroendocrine Tumors / drug therapy
  • Neuroendocrine Tumors / genetics*
  • Pancreatic Neoplasms / drug therapy
  • Pancreatic Neoplasms / genetics*
  • Polymorphism, Genetic
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Quinazolines
  • ErbB Receptors
  • Gefitinib

Associated data

  • GENBANK/X00588